Amyloid precursor protein (APP) is a transmembrane protein implicated in synapse formation and synaptic plasticity [1] [2] [3] . The secreted extracellular domain of APP (sAPPα) has growth-factor properties and promotes neuritogenesis. Cleavage of APP by β-and γ-secretases releases neurotoxic peptides, including Aβ, whose accumulation is directly linked to the pathogenesis of neurodegenerative disorders such as Alzheimer's disease. Several studies also support the notion that overproduction of APP underlies Alzheimer's disease [4] [5] [6] [7] [8] . Elevated APP mRNA levels can result from altered APP transcription, although the specific transcription factors involved remain elusive 9-11 . By contrast, there is extensive evidence that APP expression is potently regulated by post-transcriptional mechanisms such as APP mRNA stabilization and APP translation [12] [13] [14] [15] [16] [17] [18] , indicating that the regulation of APP mRNA metabolism is an important event in Alzheimer's disease pathophysiology.
a r t i c l e s
Amyloid precursor protein (APP) is a transmembrane protein implicated in synapse formation and synaptic plasticity [1] [2] [3] . The secreted extracellular domain of APP (sAPPα) has growth-factor properties and promotes neuritogenesis. Cleavage of APP by β-and γ-secretases releases neurotoxic peptides, including Aβ, whose accumulation is directly linked to the pathogenesis of neurodegenerative disorders such as Alzheimer's disease. Several studies also support the notion that overproduction of APP underlies Alzheimer's disease [4] [5] [6] [7] [8] . Elevated APP mRNA levels can result from altered APP transcription, although the specific transcription factors involved remain elusive [9] [10] [11] . By contrast, there is extensive evidence that APP expression is potently regulated by post-transcriptional mechanisms such as APP mRNA stabilization and APP translation [12] [13] [14] [15] [16] [17] [18] , indicating that the regulation of APP mRNA metabolism is an important event in Alzheimer's disease pathophysiology.
Post-transcriptional processes are major mechanisms by which mammalian cells control gene expression 19 . Changes in mRNA turnover and translation rates are particularly important for altering the levels of expressed proteins 20 . These events are governed by two major types of trans-binding factors that interact with the mRNA: turnover-and translation-regulatory RNA-binding proteins (TTR RBPs) and noncoding RNAs (ncRNAs) such as microRNAs (miRNAs). TTR RBPs and ncRNAs bind to cis elements on the mRNA, frequently at the 5′ and 3′ untranslated regions (UTRs). APP expression was shown to be influenced by 3′-UTR cis-elements that constitute the target sites of several miRNAs 12, 13 as well as by TTR RBPs that increased APP mRNA stability (hnRNP C) or promoted APP mRNA decay (nucleolin) 14, 15 . APP translation was also modulated by 5′-UTR cis-elements, including an iron-responsive element and an internal ribosome entry site (IRES) 16, 17 . Additionally, APP translation was shown to be modulated by a TTR RBP, the fragile X mental retardation protein (FMRP) , that associated with a coding-region cis-element and repressed APP translation 18 .
In a recent survey, we identified several RBPs that interacted with different regions of human APP mRNA. Among the novel interactions discovered, the RBP hnRNP C was found to bind the same segment of the APP coding region as did FMRP. We present evidence that hnRNP C promotes APP translation, whereas FMRP represses it, and that the two RBPs interact with the APP coding region in a competitive fashion. Moreover, repression of APP translation was linked to the colocalization of FMRP and a tagged APP RNA in processing bodies (PBs), where nontranslating mRNAs assemble. These results link the repression of APP translation to the recruitment of the FMRP-APP mRNA complex to PBs and further suggest that hnRNP C promotes APP translation by competing with FMRP, in turn blocking the recruitment of APP mRNA to PBs.
RESULTS

The APP coding region associates with RBPs hnRNP C and FMRP
To study the regulation of APP expression by RBPs, we silenced various TTR RBPs by transfecting the human neuroblastoma cell line BE2-M17 with the corresponding small interfering RNAs (siRNAs). This initial survey (Supplementary Fig. 1 ) revealed that APP abundance was altered after lowering FMRP and hnRNP C levels. We first tested whether FMRP and hnRNP C associated with the APP mRNA by immunoprecipitation of native RNP complexes, followed by detection a r t i c l e s of the APP mRNA in the RNP complexes by reverse transcription and quantitative PCR (qPCR) amplification. The APP mRNA was significantly enriched in both the hnRNP C (P < 0.05; Fig. 1a , top, and Supplementary Fig. 1 ) and FMRP immunoprecipitations (P < 0.01; Fig. 1a , bottom), in keeping with previous reports that hnRNP C and FMRP associated with the APP mRNA 14, 18 . Further studies were then conducted to identify the regions of interaction by testing biotinylated fragments of the APP mRNA ( Fig. 1b and Supplementary Fig. 2 ). hnRNP C had affinity for the 3′ UTR (segment G) and, unexpectedly, also for the APP coding region (segment C) (Fig. 1a) . Although hnRNP C is predominantly nuclear, it is also readily detected in the cytoplasm, albeit in lower abundance (Supplementary Fig. 3 ).
We sought evidence that FMRP and hnRNP C interacted with fragment C in intact cells by analysis of RNP cross-linking before lysis and immunoprecipitation (CLIP). CLIP analysis revealed the association of each RBP with APP fragment C in the cell (Fig. 1c) , indicating that the RNPs shown in Figure 1a occurred in intact cells and did not arise from the reassociation of FMRP or hnRNP C with APP mRNA after membrane disruption. Because both hnRNP C and FMRP associated with fragment C (whereas other RBPs tested did not, Supplementary Fig. 2) , we hypothesized the existence of a functional link between the two RBPs on the APP coding region, and we set out to study this possibility.
hnRNP C and FMRP modulate APP mRNA translation
We first investigated whether hnRNP C and FMRP were directly involved in regulating APP expression by silencing hnRNP C or FMRP using siRNA, which effectively reduced hnRNP C and FMRP levels in BE2-M17 cells (Fig. 2a) Lysates prepared from cells that were transfected as described in a were fractionated through sucrose gradients (right), and the relative distribution of APP mRNA (top) and housekeeping β-actin mRNA (bottom) was studied by RT-qPCR analysis of RNA in each of 10 gradient fractions. Arrow indicates the direction of sedimentation; -, fractions with no ribosomal components; 40S and 60S, small and large ribosome subunits, respectively; 80S, monosomes; LMWP and HMWP, low-and high-molecular weight polysomes, respectively. Below each profile, 18S and 28S rRNA were visualized by ethidium bromide staining of RNA aliquots from each fraction. Data are representative of three independent experiments. (e,f) BE2-M17 cells were transfected with either an empty vector control or an RBP expression vector (pcDNA and pcDNA-hnRNP C (e)) or (pGFP and pGFP-FMRP (f)). In each transfection group, APP protein levels were assessed by western blot analysis and quantified by densitometry using β-actin for normalization (left); APP mRNA levels in each group were measured by RT-qPCR using GAPDH mRNA for normalization (right). Data in a-c, e and f are shown as the means + s.d. from at least three independent experiments. a r t i c l e s were markedly decreased in the hnRNP C siRNA group and strongly upregulated in the FMRP siRNA group (Fig. 2a) . These changes did not arise from altered APP mRNA abundance (Fig. 2b) or protein turnover (not shown); instead, we postulated that APP translation could be influenced by these two RBPs.
We measured the rate of APP translation after incubation of BE2-M17 cells with 35 S-methionine and 35 S-cysteine for 15 min followed by APP immunoprecipitation to detect de novo-synthesized APP; as shown, translation was reduced in the hnRNP C group and was elevated in the FMRP group (Fig. 2c) . We studied the relative association of APP mRNA with polyribosomes, an indirect measure of its translation, by fractionating the cytoplasmic components on sucrose gradients (representative sucrose gradient profiles are shown in Fig. 2d , right, and Supplementary Fig. 4 ). Fractionation was followed by measurement of the levels of APP mRNA (by RTqPCR) in each fraction: untranslated (fractions 1 and 2), ribosome subunits and monosomes (fractions 3-5), low-molecular weight polysomes (fractions 6-8) and high-molecular weight polysomes (fractions 9-12). Compared with the distribution of APP mRNA in control siRNA cells (peaking at fraction 10), silencing hnRNP C shifted the APP mRNA distribution to lower parts of the gradient, with much of the APP mRNA peaking at fraction 8, in keeping with a reduction in APP translation in the hnRNP C siRNA population. Conversely, silencing FMRP increased the relative abundance of APP mRNA in the highest translating fraction (fraction 10), which contained 33% of the APP mRNA from control siRNA cells and 41% of APP mRNA from FMRP siRNA cells. These data reveal a greater proportion of large polysomes translating APP after silencing FMRP. FMRP and hnRNP C specifically altered the translational status of the APP mRNA, as the profiles for the mRNA encoding the housekeeping protein β-actin were quite similar among the silencing groups (Fig. 2d, left) .
To further test the possibilities that FMRP reduced APP translation and hnRNP C promoted it, we overexpressed each RBP by transfection using plasmid vectors and then measured APP levels. As shown, hnRNP C overexpression increased APP protein but not APP mRNA levels ( Fig. 2e and Supplementary Fig. 5 ), whereas FMRP overexpression decreased APP protein but not APP mRNA levels ( Fig. 2f and Supplementary Fig. 5 ). Together with the silencing data, these results indicate that FMRP functions as a repressor of APP translation in human neuroblastoma BE2-M17 cells (as previously shown in mouse neurons 18 ) and further suggest that hnRNP C functions as an enhancer of APP translation.
Regulation of APP expression through the APP coding region
Next, we sought to identify the regions of APP mRNA implicated in this translational control using reporter constructs. As hnRNP C associated prominently with the APP 3′ UTR segment G (3′ UTR(G)) (Fig. 1b) , we first tested the contribution of this RNA region by preparing a construct that expressed a chimeric RNA containing APP fragment G at the 3′ UTR (EGFP + 3′ UTR(G); Fig. 3a ). When we compared control siRNA-and hnRNP C siRNA-transfected cells, expression of the control EGFP reporter mRNA was unchanged, but expression of EGFP + 3′ UTR(G) reporter mRNA was reduced in the hnRNP C siRNA group, as assessed both by western blot analysis ( Fig. 3b) and by fluorescence microscopy (Fig. 3c) . This reduction was not due to a decrease in EGFP + 3′ UTR(G) mRNA abundance-these levels remained unchanged, as measured using RT-qPCR (Fig. 3d) . Instead, the altered EGFP expression appeared to be due to modest upregulation of EGFP translation in the presence of hnRNP C through the 3′ UTR(G) sequence.
Because both hnRNP C and FMRP associated with segment C of the APP coding region (CR(C)), we tested the contribution of their interaction at this RNA region by using a reporter construct in which region C was inserted in frame into the coding region of EGFP (EGFP + CR(C)) (Fig. 4a) . Expression of the control EGFP reporter protein was unchanged among the transfection groups. By contrast, expression of EGFP + CR(C) protein was lower in the hnRNP C siRNA group and was higher in the FMRP siRNA group, as tested both by western blot analysis ( Fig. 4b) and by fluorescence microscopy (Fig. 4c) . As seen with the 3′ UTR reporter (Fig. 3) , the changes in EGFP + CR(C) protein levels were not due to altered EGFP + CR(C) mRNA abundance (Fig. 4d) and were instead attributed to altered translation rates in the hnRNP C and FMRP siRNA transfection groups. We tested this notion further by overexpressing hnRNP C, which enhanced reporter EGFP protein levels without significantly (P > 0.05) altering the levels of EGFP or EGFP + CR(C) mRNAs (Fig. 4e) . On the other hand, FMRP overexpression lowered reporter EGFP Fig. 1b) . (b) By 48 h after transfection of either control (Ctrl) or hnRNP C-directed siRNAs, together with each reporter plasmid, the levels of EGFP, hnRNP C and loading control β-actin were assessed by western blot analysis and quantified by densitometry. a r t i c l e s protein levels but did not significantly (P > 0.05) alter the levels of EGFP or EGFP + CR(C) mRNAs (Fig. 4f) . In sum, FMRP can reduce the translation of a reporter construct through APP CR(C), whereas hnRNP C can enhance translation strongly through the APP CR(C) and modestly through the APP 3′ UTR(G).
hnRNP C and FMRP competitively bind APP mRNA As both hnRNP C and FMRP could associate with APP CR(C) but had opposite effects on APP mRNA levels, we postulated that hnRNP C and FMRP might compete for interaction with the APP mRNA. To test this hypothesis, we studied the binding of hnRNP C in cells expressing normal (control siRNA) or reduced (FMRP siRNA) levels of FMRP; as shown (Fig. 5a) , silencing FMRP resulted in greater levels of the RNP complex (hnRNP C-APP mRNA) than were seen in cells with normal FMRP levels. Conversely, a comparison of cells expressing normal (control siRNA) or reduced levels of hnRNP C (hnRNP C siRNA) showed that the RNP complex (FMRP-APP mRNA) was more abundant in cells with silenced hnRNP C than in cells with normal hnRNP C levels (Fig. 5b) . We recapitulated these findings using EGFP reporters: EGFP + CR(C) mRNA was significantly more enriched (P < 0.01) in hnRNP C immunoprecipitation samples after silencing FMRP (Fig. 5c) , whereas the same reporter mRNA was more prominently associated with FMRP after silencing hnRNP C (Fig. 5d) . To study the competition between FMRP and hnRNP C in a neurological disease model, we used mice lacking FMR1 (Fmr1 KO) 21 . The steady-state abundance of mouse APP (mAPP) mRNA in whole-brain RNA was comparable between wild-type (WT) and Fmr1 KO mice (Fig. 5e) . However, the interaction of hnRNP C with mouse mAPP mRNA was significantly more abundant (P < 0.05) in Fmr1 KO brain lysates than in WT brain lysates (Fig. 5f) , associated with significantly higher expression (P < 0.05) of APP protein in the Fmr1 KO mice (Fig. 5g, in agreement  with earlier findings 18 ) . Collectively, these observations support the view that hnRNP C and FMRP compete for association with the APP coding region and further indicate that translation increases if the APP coding region associates with hnRNP C, whereas it decreases if the APP coding region associates with FMRP.
FMRP recruits APP mRNA to processing bodies Recently, several studies have shown that FMRP colocalizes with PBs, where nontranslating mRNAs accumulate and can be sorted for transient storage or degradation [22] [23] [24] [25] . First, we tested whether Argonaute (Ago) proteins, which function as translational repressors, were functionally linked to the inhibitory activity of FMRP. FMRP overexpression a r t i c l e s significantly increased (P < 0.05) the association of APP mRNA with hemagglutinin (HA)-tagged Ago1 and Ago2 proteins (Fig. 6a) , which are PB-resident proteins. In keeping with the suppression of gene expression by Ago proteins, overexpression of HA-Ago1 or HA-Ago2 each reduced basal APP abundance, although it did not prevent the increase in APP levels that ensued upon silencing FMRP (Fig. 6b) . FMRP and Ago associated by RNA-independent proteinprotein interaction, as determined by immunoprecipitation followed by western blot analysis in the presence of RNases (Fig. 6c) . This analysis also revealed the interaction of FMRP with RCK, a component of PBs implicated in translational repression 26 (Fig. 6c) . It is noteworthy that FMRP did not repress APP translation in the absence of RCK, Ago1 or Ago2 (Supplementary Fig. 6 ). We further studied the distribution of FMRP and PBs by immunofluorescence, which revealed extensive colocalization of FMRP with Ago2 as well as with the PB markers Dcp1 and Rck (Fig. 6d) . These data indicate that, in human neuroblastoma BE2-M17 cells, FMRP is highly abundant in PBs.
To investigate directly whether the localization of FMRP in PBs is implicated in FMRP's repression of APP translation, we studied the subcellular localization of APP mRNA. First, we tested the presence of APP mRNA in PBs by performing anti-RCK RNP immunoprecipitation followed by RT-qPCR to detect APP mRNA. When FMRP was overexpressed, APP mRNA was significantly more abundant (P < 0.05) in RCK immunoprecipitation samples, suggesting that FMRP Fig. 7a ). However, because not all RCK may be present in PBs, we sought to study the subcytoplasmic localization of APP mRNA in intact cells. To this end, we prepared the reporter construct pMS2-APP (details in Online Methods), which expressed a chimeric RNA (MS2-APP) comprising the APP CR(C) segment and 24 tandem MS2 RNA hairpins (Fig. 7a) . Co-transfection of pMS2-APP together with plasmid pMS2-YFP, which expressed the chimeric fluorescent protein MS2-YFP with a nuclear localization signal (see Online Methods), allowed us to track the subcellular localization of the chimeric MS2-APP RNA (as the MS2-YFP-MS2-APP complex) as well as the control MS2 RNA (as the MS2-YFP-MS2 complex) by confocal microscopy. Despite potential artifacts, the MS2 system has been used successfully to track the subcellular localization of RNAs 27 . The control MS2 RNA appeared to be exclusively nuclear in all of the transfected cells (Fig. 7b, left) due to the presence of the nuclear localization signal (Fig. 7a) . By contrast, some MS2-APP RNA was retained the cytoplasm with a punctate pattern, colocalizing to some extent (but not exclusively) with RCK signals; colocalization results in yellow signals in the merged images (Fig. 7b , right, arrowheads, and Supplementary   Fig. 7 ). The colocalization of MS2-YFP-MS2-APP and RCK signals was lost in the transfected cells when we overexpressed hnRNP C (Fig. 7c, right) but was seen in the corresponding control cells (Fig. 7c, left) . Similarly, the colocalization of MS2-YFP-MS2-APP and RCK signals was lost when we silenced FMRP (Fig. 7d, middle) but was seen in the corresponding control cells (Fig. 7d, left ) and in cells with silenced hnRNP C (Fig. 7d, right) . Together, these results support the view that FMRP represses APP mRNA translation at least in part by recruiting the transcript to PBs. According to this paradigm, hnRNP C promotes translation by competing for the interaction of FMRP with the APP coding region, thereby preventing the localization of APP mRNA at PBs (Fig. 8) .
DISCUSSION
We found that hnRNP C and FMRP competed for binding to the coding region of APP mRNA and modulated APP translation in opposite directions: hnRNP C enhanced APP translation, whereas FMRP repressed it. We reached these conclusions by analyzing both the endogenous APP mRNA and reporter constructs bearing the ~120-nt APP CR(C) where binding by these RBPs was mapped. As shown, silencing FMRP promoted binding of hnRNP C to APP mRNA and enhanced APP translation, whereas silencing hnRNP C increased FMRP binding to APP mRNA and lowered APP translation. Accordingly, FMRP overexpression inhibited APP translation, whereas hnRNP C overexpression increased it (Figs. 2, 4 and 5) . Our results confirm and expand upon the findings of previous work 18 showing that FMRP bound to a G-rich (G quartet-like) coding-region segment in the APP coding region and repressed APP translation in mouse neurons. That research further showed that the inhibitory interaction of FMRP with the APP coding region was relieved after treatment with DHPG, an agonist of the metabotropic glutamate receptor (mGluR) 18 . FMRP was previously shown to suppress strongly and specifically the translation of several mRNAs in rabbit reticulocyte lysates and in microinjected oocytes 28 . En masse analysis of FMRP RNP complexes revealed altered translational profiles for many target transcripts 29 ; Figure 8 Model of competition between FMRP and hnRNP C to modulate APP translation. Schematic representation of the proposed competition by FMRP and hnRNP C on the APP coding region. As shown, the enhanced interaction of FMRP with the APP coding region reduces APP translation by recruiting the APP mRNA to PBs, whereas the increased association of hnRNP C increases APP translation. We hypothesize that the rate of APP biosynthesis is directly influenced by the relative association of each RBP. FMRP was generally found to bind target mRNAs in the 5′ and 3′ UTRs 29, 30 . The precise mechanisms of translational repression by FMRP are unclear, but the RBP appears to prevent the assembly of the 80S monosome on target mRNAs, and its phosphorylation correlates with its presence in stalled polyribosomes 27, [31] [32] [33] . Earlier studies also provided evidence that FMRP associated with the RNA interference effector complex RNA-induced silencing complex, suggesting a link between FMRP and the inhibition of translation through the miRNA pathway [34] [35] [36] [37] . More recently, FMRP was implicated in the assembly of stress granules, which form transiently in response to cellular damage; this finding is potentially relevant to the translational repression by FMRP, since stress granules are believed to contain untranslated mRNAs that are subject to RNP remodeling to modulate their subsequent turnover and translation rates 38 . Our findings support the view that FMRP represses APP translation at least in part by reducing the rate of translation initiation (as a larger population of heavy polyribosomes is seen after silencing FMRP, Fig. 2d) , by reducing nascent APP translation (Fig. 2c) and translation of a reporter RNA (Fig. 4) and by recruiting a tagged APP RNA (containing CR(C)) to PBs (Figs. 6d and 7) , where nontranslating mRNAs accumulate [22] [23] [24] [25] . It remains to be seen whether FMRP also inhibits APP translation by stalling preinitiation complexes or by recruiting the APP mRNA onto stress granules, RNA-induced silencing complex or other cellular machineries.
The mechanisms whereby hnRNP C promotes APP translation are also unclear at present. hnRNP C1/C2 was previously suggested to promote polyadenylation and enhanced the initiation of upstream of N-Ras (Unr) translation during mitosis 39, 40 . The promotion of Unr translation by hnRNP C was shown to be mediated by an IRES, antagonizing the polypyrimidine tract-binding protein. Notably, the APP mRNA also has a functional IRES in the 5′ UTR 17 . Although it lies several hundred nucleotides away from the G-rich region of association with hnRNP C, it will be interesting to study whether the promotion of APP translation by hnRNP C is related to the APP IRES. Nonetheless, our results indicate that hnRNP C overexpression increases the initiation of APP mRNA translation (Fig. 2d) , overall de novo APP translation (Fig. 2c) and the translation of a reporter mRNA (Fig. 4) and blocked the recruitment of tagged APP RNA to PBs (Fig. 7) . In light of our results showing that hnRNP C promotes APP translation by competing with FMRP for binding to the APP coding region, it will also be important to study whether hnRNP C competes with FMRP for the binding of other FMRP target mRNAs identified previously 29 and whether hnRNP C stimulates their translation.
How PBs repress the translation of resident mRNAs is not fully understood. However, PBs contain many translational repressors, including decapping enzymes (DCP1 and DCP2), mRNA deadenylation factors (for example, the CCR4-CAF-1-Not complex), activators of decapping (Dhh1/RCK/p54, Pat1, Scd6/RAP55, Edc3 and the Lsm1-7 complex) and exonucleases (for example, XRN-1) [41] [42] [43] . FMRP interacts with Ago proteins and the miRNA pathway, suggesting that miRNAs could also participate in controlling APP translation. miRNAs, such as miR-106a/b, miR-520c, miR-20a and miR-17-5p, associate with the APP 3′ UTR and contribute to repressing its translation 12, 13 . It is not known at this time whether such interactions are functionally linked to the actions of FMRP or hnRNP C, although these miRNAs interact with regions outside of CR(C). Also awaiting experimental analysis is whether stresses can alter the binding of any of the factors (RBPs, microRNAs) that interact with the APP mRNA.
In studies that examined the APP 3′ UTR, hnRNP C and nucleolin were shown to bind to a 29-nt sequence in the APP 3′ UTR, and they increased APP mRNA stability in rabbit reticulocyte lysates 14 . In agreement with these findings, we also observed extensive binding of hnRNP C to the APP 3′ UTR (Fig. 1) ; however, we did not observe significant differences in APP mRNA levels or stability under the conditions of our study, perhaps because the two cell types differ in this respect (Fig. 3 and data not shown) . Several other RBPs were also found to influence APP expression. HuD bound the APP mRNA at the 3′ UTR (Supplementary Fig. 1) , and silencing lowered APP mRNA and protein levels ( Supplementary Fig. 1 and data not  shown) . However, given the long half-life of APP mRNA (t 1/2 > 12 h (ref. 44) (data not shown)), it seems that HuD may regulate APP expression indirectly, perhaps by affecting the expression of a transcription factor that controls APP gene transcription.
In closing, RBPs such as FMRP and hnRNP C, together with miRNAs that interact with the APP mRNA, are emerging as pivotal post-transcriptional regulators of APP production. These factors help to ensure that APP is expressed in the correct abundance, as dictated by the developmental and metabolic state of the cell. Given the multiplicity of factors controlling the turnover and translation of APP mRNA, further studies are warranted to elucidate their complex interactions. Although the physiologic function of APP is not understood completely, the levels of APP directly affect the levels of processed Aβ. Thus, a thorough knowledge of the control of APP levels is critical to understand how Alzheimer's disease arises and to develop effective interventions.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Cell culture, transfection, small interfering RNAs and plasmids. We cultured human neuroblastoma BE2-M17 cells in Opti-MEM and DMEM (Invitrogen) supplemented with 10% (v/v) FBS. We transfected siRNAs targeting hnRNP C and FMRP (sc-35577 and sc-36870, Santa Cruz Biotechnology) and control siRNA (Qiagen), comprising three pooled siRNAs without known off-target effects, at 20 nM final concentration using oligofectamine (Invitrogen), and we analyzed cells 48 h later. We constructed reporter plasmids by inserting fragments from the APP 3′ UTR (2232-2635) and the coding region (901-1020) into plasmid pEGFP-C1 (BD Bioscience) 45 . To overexpress hnRNP C, we prepared an expression vector by amplifying the hnRNP C coding region (NM_031314.2) using PCR and ligating it at BamHI and XhoI sites of plasmid pcDNA3 using primers ACTTAGGATCCATGGCCAGCAACGTTACC and ACTCATCTCGA GTTAAGAGTCATCCTCGCCATTG. R. Willemsen (Erasmus MC) kindly provided pEGFP-FMRP. We obtained HA-Ago1 and HA-Ago2 from Addgene. We prepared pMS2-APP from plasmid pSL-MS2(24X). R.H. Singer (Albert Einstein College of Medicine) generously provided plasmids pSL-MS2 and pMS2-YFP 25 . We inserted MS2-YFP cDNA into plasmid pcDNA3 to increase expression levels (see below). We ligated the MS2 hairpin sequence (24 repeats) from pSL-MS2 at EcoRI and EcoRV sites and APP CR(C) at the XhoI site of pcDNA3. We used lipofectamine 2000 (Invitrogen) for plasmid transfections.
Western blot analysis. We used RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% (v/v) Nonidet P-40, 1 mM EDTA, 0.1% (w/v) SDS and 1 mM DTT) to prepare whole-cell lysates, separated them by electrophoresis in SDS-containing polyacrylamide gels and transferred them onto PVDF membranes (Millipore). We used primary antibodies that recognized APP (Calbiochem), hnRNP C, GFP (Santa Cruz Biotechnology), FMRP (Chemicon) or β-actin (Abcam), incubated the blots with the appropriate secondary antibodies conjugated with HRP (GE Healthcare) and detected the protein signals using enhanced luminescence (GE Healthcare).
RNA analysis. We used Triazol (Invitrogen) to prepare total RNA directly from cells or after immunoprecipitation from cellular RNA-protein complexes obtained by immunoprecipitation (using anti-FMRP (Abcam), anti-hnRNP C (Santa Cruz Biotechnology) or IgG antibodies) as described 46 (see also below). After reverse transcription using random hexamers and SSII reverse transcriptase (Invitrogen), we assayed the abundance of transcripts by real-time qPCR analysis using SYBR Green PCR master mix (Applied Biosystems) and the following gene-specific primer sets: for APP mRNA GCCAAAGAGACATGCAGTGA and AGTCATCCTCCTCCGCATC; for GADPH mRNA, TGCACCACCAA CTGCTTAGC and GGCATGGACTGTGGTCATGAG; and for β-actin mRNA, GGACTTCGAGCAAGAGATGG and AGCACTGTGTTGGCGTACAG.
Immunoprecipitation assays. We prepared whole-cell lysates by incubating cells in RIPA buffer for 10 min on ice followed by centrifugation at 10,000g for 15 min at 4 °C. We incubated the supernatants with Protein A-Sepharose beads coated with primary antibody or control IgG (Santa Cruz Biotechnology) with or without RNaseT (Invitrogen) for 16 h. After washing the beads with RIPA buffer, we assayed the complexes by western blot analysis as described above.
Using whole-cell extracts, we performed immunoprecipitation of native RNP complexes as described 46 using primary antibodies (anti-hnRNP C or control IgG, Santa Cruz Biotechnology; anti-FMRP, Abcam). After washes and digestion with DNase I and Proteinase K, we analyzed the RNA in the immunoprecipitation samples by RT-qPCR using the primers described above. We performed immunoprecipitation of cross-linked RNP complexes as described 47 . After RNase T1 digestion, we isolated RNA and analyzed it by RT-qPCR using primers that amplified segment C of the coding region (below).
Mouse brain analysis.
We harvested whole brains from WT (4 female, 1 male) or Fmr1 KO (5 female) FvB mice 21 , 4-5 months of age. To prepare brain homogentes, we used polysome extraction buffer (20 mM Tris-HCl, pH 7.5, 100 mM KCl, 5 mM MgCl 2 and 0.5% (v/v) Nonidet P-40) containing RNAse-OUT and 1X protease inhibitor cocktail, followed by centrifugation at 20,000g for 30 min at 4 °C. We incubated the lysates (2-mg aliquots) with beads that were precoated with antibody (15 μg anti-hnRNP C or IgG) for 2 h at 4 °C. Subsequent steps are as described above.
